PFIZER INC (PFE)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for PFE
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| PFE | President and CEO of the University of Miami; Committee Member; Chairman of the Governance Committee | 69 | ["Chair","Business Leadership & Operations","Finance & Accounting","International Business","Risk Management","Government & Public Policy","Independent","Financially Literate","Audit Committee Financial Expert"] | ["Audit","Governance","Audit Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| BK | Lead Director of The Bank of New York Mellon Corporation; Retired CEO of Deloitte LLP | 69 | ["Leadership of a large, global company","Financial expert, with expertise in accounting, regulatory and compliance issues","Senior level policy-making experience in the field of professional services"] | ["Audit","Corp. Gov., Nom. & Social Resp.","Finance","Corporate Governance","Nominating","Social Responsibility","Finance (Chair)"] | 2026 |
| UNM | Independent Director | 69 | ["Finance","Accounting","Global Operations","Executive Management","Corporate Governance","Certified Public Accountant"] | ["Governance","Risk and Finance","Audit","Risk & Finance"] | 2026 |
| XRX | Director | 64 | ["Former Chief Executive Officer of Deloitte LLP","B.B.A., University of Miami","Leadership","Global Business","Financial","Business Operations","Diversity","Public Company Boards & Governance"] | ["Audit","Finance"] | 2021 |
Biography sourced from the proxy statement filing.
Joseph J. Echevarria serves as the President of the University of Miami (UM) and holds the position of Chair at Pfizer Inc. Echevarria's career has been marked by significant leadership roles in both the corporate and academic sectors. Before joining UM in 2015, he spent over 30 years at Deloitte, where he rose to become the CEO, overseeing the firm's global operations and driving strategic growth initiatives. His tenure at Deloitte was characterized by his commitment to enhancing client services and fostering a culture of innovation.
As the President of UM, Echevarria has been instrumental in steering the university towards greater academic excellence and global engagement. Under his leadership, UM has expanded its research initiatives and international partnerships, reinforcing its reputation as a leading institution of higher learning. In addition to his role at UM, Echevarria serves as the Chair of Pfizer's Board of Directors. He joined Pfizer's board in 2015 and was appointed Chair in 2021, bringing his extensive experience in business leadership and operations to the company. As an independent board member, Echevarria plays a crucial role in guiding Pfizer's strategic direction and ensuring effective corporate governance.
Echevarria's contributions to Pfizer extend beyond his role as Chair. He is a member of the Audit Committee and brings his expertise in finance and accounting to the table. His background in risk management and international business further enhances his ability to provide valuable insights and oversight. Echevarria's leadership at Pfizer has been particularly significant during the company's efforts to navigate the challenges of the global pharmaceutical market and to advance its mission of delivering innovative healthcare solutions. His diverse skill set, including his experience in government and public policy, positions him well to address the complex issues facing the industry.
Outside of his professional roles, Echevarria is known for his commitment to community service and philanthropy. He has been actively involved in various charitable organizations, focusing on education and healthcare initiatives. His leadership style is characterized by a strong emphasis on collaboration, integrity, and a forward-thinking approach to problem-solving. Echevarria's dual roles at UM and Pfizer exemplify his dedication to driving positive change in both the academic and corporate worlds.